Sandoz Recalls Ephedrine Sulfate Injection Due to Sterility Concerns
Sandoz Inc. is recalling specific lots of Ephedrine Sulfate Injection because an FDA inspection raised concerns that the product's sterility may be compromised.
What this means for you
Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The recall is classified as FDA Class II. According to the rubric, an FDA Class II recall involving a significant hazard such as compromised sterility in an injectable drug warrants a 'Severe' rating (Score 4), particularly given the potential for serious injury from non-sterile medical products.
Plain-English summary
Sandoz Inc. is recalling 32,099 cartons of Ephedrine Sulfate Injection, USP, 50 mg/mL, 1 mL Fill in a 2mL Vial (NDC 66758-008-01). The product is packaged in 25 x 2 mL Vials per carton (NDC 66758-008-02) and is available by prescription only. The recall covers specific lots with expiration dates of 08/16 and 09/16.
The recall was initiated because a recent FDA inspection at the manufacturing facility raised concerns that the sterility of the product may be compromised. This lack of assurance of sterility poses a potential risk to patients who receive the injection.
The affected product was distributed nationwide and in Puerto Rico. Healthcare providers and patients should stop using the recalled lots and contact Sandoz Inc. for further instructions or replacements.
The recalled product
- Product
- Ephedrine Sulfate Injection, USP, 50 mg/mL, 1 mL Fill in a 2mL Vial (NDC 66758-008-01), packaged in 25 x 2 mL Vials per carton (NDC 66758-008-02), Rx only, Manufactured for: Sandoz Inc., Princeton, NJ 08540.
- Manufacturer
- Sandoz Inc
- Category
- Drug — Injectable
- Affected units
- 32,099
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (19)
- Lot #: 080514
- 080614
- 081114
- 081214
- 081314
- 081414
- 082714
- 082814
- 082914
- Exp 08/16
- 090214
- 090314
- 090814
- 090914
- 091014
- 091114
- 091214
- 091514
- Exp 09/16
Distribution
Part of a larger recall action
This product is one of 2 recalled by Sandoz Inc under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 2 products in this recall →Related recalls
Same manufacturer · Sandoz Inc
See all →- LowFocalin XR 5mg capsules carry incorrect or missing lot and expiry
FDA (Drugs) · 2026-06-24
- ModerateCyclophosphamide injection vials recalled after a transportation temperature excursion
FDA (Drugs) · 2025-09-24
- ModerateCiprofloxacin and dexamethasone otic suspension recalled following temperature abuse
FDA (Drugs) · 2025-09-17
- SevereBuffered penicillin G potassium vials may actually contain cefazolin for injection
FDA (Drugs) · 2025-07-09
- SevereSandoz cefazolin cartons contained vials labeled as penicillin G potassium
FDA (Drugs) · 2025-07-09
Same hazard · sterility compromise
See all →- SevereSpectra Medical Devices Recalls Sodium Chloride Injection Ampules Due to Sterility Concerns
FDA (Devices) · 2026-08-19
- HighStryker Recalls Ahto Dual Spike Tube Set Due to Leaking Handpiece
FDA (Devices) · 2026-08-12
- HighIntramedullary Bone Saw Blade Assembly Recalled Due to Potential Sterile Barrier Damage
FDA (Devices) · 2026-08-12
- ModerateIntramedullary Bone Saw Blade Assembly Recalled Due to Potential Sterile Barrier Damage
FDA (Devices) · 2026-08-12
- HighIntramedullary Bone Saw Blade Assemblies Recalled Due to Potential Packaging Damage
FDA (Devices) · 2026-08-12